MDNA News & Mentions

Popular stocks:

Mullen Automotive

TOP stocks:

Shares of other companies:

Greenidge Generation Holdings

Foghorn Therapeutics

Southern

Best Buy Co.

Dicerna Pharmaceuticals

Medicenna Therapeutics (MDNA) stock Forecast for 2022 – 2026

Last update: March 23, 2023 (16:02)

Sector: Healthcare

The share price of Medicenna Therapeutics Corp. (MDNA) now

What analysts predict: $6.12

52-week High/Low: $1.88 / $0.397

50/200 Day Moving Average: $0.639 / $0.821

This figure corresponds to the Average Price over the previous 50/200 days. For Medicenna Therapeutics stocks, the 50-day moving average is the resistance level today.

For Medicenna Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Medicenna Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medicenna Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Medicenna Therapeutics share be worth in 2023 - 2027?

When should I take profit in Medicenna Therapeutics stock? When should I record a loss on Medicenna Therapeutics stock? What are analysts' forecasts for Medicenna Therapeutics stock? What is the future of Medicenna Therapeutics stock? We forecast Medicenna Therapeutics stock performance using neural networks based on historical data on Medicenna Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Medicenna Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Medicenna Therapeutics shares. This happens once a day.

Historical and forecast chart of Medicenna Therapeutics stock

The chart below shows the historical price of Medicenna Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Medicenna Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Subscribe for Forecasts Update!

Medicenna Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Mar 25	0.55	0.53	0.56	5.83
Mar 26	0.55	0.53	0.55	3.95
Mar 27	0.53	0.51	0.54	5.31
Mar 28	0.54	0.53	0.55	2.46
Mar 29	0.56	0.54	0.57	5.78
Mar 30	0.56	0.55	0.58	6.01
Mar 31	0.55	0.54	0.57	4.89
Apr 01	0.56	0.55	0.57	2.35
Apr 02	0.57	0.55	0.58	5.19
Apr 03	0.55	0.54	0.57	6.03
Apr 04	0.56	0.54	0.57	5.56
Apr 05	0.55	0.54	0.56	4.83
Apr 06	0.54	0.54	0.55	2.58
Apr 07	0.54	0.53	0.55	4.98
Apr 08	0.54	0.52	0.55	6.22
Apr 09	0.53	0.52	0.55	5.83
Apr 10	0.54	0.53	0.55	3.85
Apr 11	0.53	0.52	0.55	5.44
Apr 12	0.52	0.52	0.53	2.99
Apr 13	0.51	0.50	0.52	3.92
Apr 14	0.50	0.50	0.52	3.95
Apr 15	0.50	0.49	0.51	3.60
Apr 16	0.51	0.50	0.52	3.32
Apr 17	0.53	0.52	0.54	4.36
Apr 18	0.54	0.52	0.55	5.44
Apr 19	0.53	0.52	0.53	3.36
Apr 20	0.53	0.53	0.54	2.48
Apr 21	0.52	0.51	0.54	4.63
Apr 22	0.51	0.51	0.52	2.84
Apr 23	0.49	0.48	0.50	4.33

Medicenna Therapeutics Daily Price Targets

Medicenna Therapeutics Stock Forecast 03-25-2023.

Forecast target price for 03-25-2023: $0.55.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.512%.
Pessimistic target level: 0.53
Optimistic target level: 0.56

Medicenna Therapeutics Stock Forecast 03-26-2023.

Forecast target price for 03-26-2023: $0.55.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 3.800%.
Pessimistic target level: 0.53
Optimistic target level: 0.55

Medicenna Therapeutics Stock Forecast 03-27-2023.

Forecast target price for 03-27-2023: $0.53.
Negative dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.043%.
Pessimistic target level: 0.51
Optimistic target level: 0.54

Medicenna Therapeutics Stock Forecast 03-28-2023.

Forecast target price for 03-28-2023: $0.54.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 2.405%.
Pessimistic target level: 0.53
Optimistic target level: 0.55

Medicenna Therapeutics Stock Forecast 03-29-2023.

Forecast target price for 03-29-2023: $0.56.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.460%.
Pessimistic target level: 0.54
Optimistic target level: 0.57

Medicenna Therapeutics Stock Forecast 03-30-2023.

Forecast target price for 03-30-2023: $0.56.
Positive dynamics for Medicenna Therapeutics shares will prevail with possible volatility of 5.670%.
Pessimistic target level: 0.55
Optimistic target level: 0.58

MDNA (MDNA) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Apr.	0.65	0.56	0.70	19.32
May.	0.68	0.65	0.74	12.06
Jun.	0.66	0.57	0.73	21.91
Jul.	0.58	0.52	0.63	17.56
Aug.	0.56	0.52	0.60	13.41
Sep.	0.63	0.59	0.70	16.71
Oct.	0.63	0.60	0.71	16.27
Nov.	0.63	0.54	0.71	23.90
Dec.	0.66	0.62	0.69	10.21

Full forecast for 2023

Medicenna Therapeutics forecast for this year

Medicenna Therapeutics Stock Prediction for Apr 2023

An uptrend is forecast for this month with an optimal target price of $0.646179. Pessimistic: $0.56. Optimistic: $0.70

Medicenna Therapeutics Stock Prediction for May 2023

An uptrend is forecast for this month with an optimal target price of $0.680556. Pessimistic: $0.65. Optimistic: $0.74

Medicenna Therapeutics Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $0.655988. Pessimistic: $0.57. Optimistic: $0.73

Medicenna Therapeutics Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $0.584944. Pessimistic: $0.52. Optimistic: $0.63

Medicenna Therapeutics Stock Prediction for Aug 2023

An downtrend is forecast for this month with an optimal target price of $0.563828. Pessimistic: $0.52. Optimistic: $0.60

Medicenna Therapeutics Stock Prediction for Sep 2023

An uptrend is forecast for this month with an optimal target price of $0.631318. Pessimistic: $0.59. Optimistic: $0.70

Medicenna Therapeutics Stock Prediction for Oct 2023

An downtrend is forecast for this month with an optimal target price of $0.627719. Pessimistic: $0.60. Optimistic: $0.71

Medicenna Therapeutics Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $0.628912. Pessimistic: $0.54. Optimistic: $0.71

Medicenna Therapeutics Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $0.66476. Pessimistic: $0.62. Optimistic: $0.69

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.78	0.66	0.87	24.01
Feb	0.84	0.77	0.92	16.72
Mar	0.74	0.64	0.80	19.50
Apr	0.69	0.66	0.73	10.75
May	0.80	0.75	0.90	16.57
Jun	0.80	0.74	0.87	14.15
Jul	0.78	0.66	0.84	21.47
Aug	0.75	0.66	0.87	24.41
Sep	0.76	0.70	0.86	18.50
Oct	0.77	0.70	0.80	12.72
Nov	0.68	0.62	0.76	17.94
Dec	0.72	0.68	0.76	10.41

Full forecast for 2024

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.68	0.65	0.74	12.04
Feb	0.59	0.51	0.63	19.99
Mar	0.68	0.64	0.72	10.48
Apr	0.76	0.65	0.86	24.48
May	0.88	0.82	0.94	12.60
Jun	0.98	0.93	1.07	13.66
Jul	0.89	0.77	0.93	17.44
Aug	0.74	0.64	0.80	20.55
Sep	0.72	0.69	0.80	13.79
Oct	0.61	0.57	0.64	11.61
Nov	0.67	0.64	0.72	10.67
Dec	0.73	0.65	0.81	19.44

Full forecast for 2025

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.70	0.60	0.76	20.69
Feb	0.64	0.59	0.70	15.96
Mar	0.73	0.70	0.82	15.14
Apr	0.78	0.70	0.84	16.07
May	0.77	0.72	0.86	16.29
Jun	0.74	0.66	0.82	19.75
Jul	0.66	0.56	0.72	22.04
Aug	0.69	0.61	0.79	22.25
Sep	0.75	0.65	0.82	20.27
Oct	0.69	0.61	0.79	23.79
Nov	0.80	0.69	0.83	16.84
Dec	0.92	0.81	0.95	15.19

Full forecast for 2026

Medicenna Therapeutics (MDNA) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.85	0.72	0.94	23.22
Feb	0.85	0.81	0.94	13.50
Mar	0.81	0.75	0.87	13.88
Apr	0.80	0.73	0.87	15.51
May	0.85	0.81	0.96	15.76
Jun	0.87	0.77	0.91	16.08
Jul	0.77	0.73	0.88	18.04
Aug	0.71	0.67	0.76	11.44
Sep	0.72	0.63	0.81	22.15
Oct	0.62	0.56	0.70	19.04
Nov	0.59	0.56	0.61	8.59
Dec	0.63	0.60	0.71	15.53

Full forecast for 2027

Medicenna Therapeutics information and performance

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

Medicenna Therapeutics Address

2 BLOOR ST W., 7TH FLOOR, TORONTO, ON, CA

Market Capitalization: 40 187 800 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -17 100 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.12

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 208.33

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.012

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 69638000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Immuron Limited (IMRN)

Koninklijke Philips N.V. (PHG)

Cumberland Pharmaceuticals Inc. (CPIX)

OKYO Pharma Limited (OKYO)

Berkeley Lights, Inc. (BLI)

Magenta Therapeutics, Inc. (MGTA)

BIOLASE, Inc. (BIOL)

Spruce Biosciences, Inc. (SPRB)

GlaxoSmithKline plc (GSK)

Clarus Therapeutics Holdings, Inc. (CRXT)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/MDNA.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/MDNA.svg"> Medicenna Therapeutics (MDNA) stock Forecast for 2022 – 2026